|
|
Article: After Plateau, 'Big Growth Phase' Due For Biotechnology: Vagelos.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
West Coast Editor
SAN FRANCISCO - Issuing a call to industry conscience while making the promise of richer times ahead, former chairman and CEO of Merck & Co. Inc., Roy Vagelos, opened the Allicense 2005 meeting with a free-ranging keynote speech that also touched upon archaic marketing methods, which "can't be a part of the future," he said.
"Marketing and sales have been pretty much the same for the last 50 years," Vagelos told a crowded room at the Westin St. Francis Hotel. "We're better at it, but we still have the paradigm where the sales representative spends two hours at the doctor's office to see the doctor for five or eight minutes."
...
Related newspaper, magazine, and journal articles:
|
|
Article: MERCK CHAIRMAN ROY VAGELOS TO JOIN PEPSICO'S BOARD OF ...
PR Newswire;
July 29, 1992 ;
700+ words
...MERCK CHAIRMAN ROY VAGELOS TO JOIN PEPSICO'S BOARD OF DIRECTORS PURCHASE ... PEP) today announced the election of P. Roy Vagelos, M.D. to the company's board of directors. Dr. Vagelos, 62, is chairman of the board and president ...
|
|